Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with l-NAME-induced hypertension

Hsin Yi Yang, Suh Ching Yang, Shu Tzu Chen, Jiun Rong Chen

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Pepsin-digested soy protein hydrolysate has been reported to be responsible for many of the physiological benefits associated with soy protein consumption. In the present study, we investigated the effects of soy protein hydrolysate with angiotensin-converting enzyme (ACE) inhibitory potential on the blood pressure and cardiovascular remodeling in rats with Nω-nitro-l-arginine methyl ester hydrochloride (l-NAME)-induced hypertension. Rats were fed a diet containing l-NAME (50 mg/kg body weight) with or without soy protein hydrolysate (1%, 3% or 5%) for 6 weeks. We found that ingestion of soy protein hydrolysate retarded the development of hypertension during the 6-week experimental period without affecting the amount of food intake. Although there was no difference in plasma ACE activity or tissue nitric oxide levels, ACE activity in the heart of rats consuming soy protein hydrolysate was significantly lower than that of the control group. Moreover, cardiac malonaldehyde and tumor necrosis factor-α concentrations were also lower in the soy protein hydrolysate group. No difference in plasminogen activator inhibitor-1 level was found in plasma or cardiovascular tissue. In the histopathological analysis, we also found that soy protein hydrolysate ameliorated inflammation and left ventricle hypertrophy in the heart. These findings suggest that soy protein hydrolysate might not only improve the balance between circulating nitric oxide and renin-angiotensin system but also show beneficial effects on cardiovascular tissue through its ACE inhibitory activity.

Original languageEnglish
Pages (from-to)833-839
Number of pages7
JournalJournal of Nutritional Biochemistry
Volume19
Issue number12
DOIs
Publication statusPublished - Dec 2008

Fingerprint

Protein Hydrolysates
Soybean Proteins
Rats
Hypertension
Peptidyl-Dipeptidase A
Enzyme activity
Tissue
Nitric Oxide
Eating
Plasmas
Pepsin A
Plasminogen Activator Inhibitor 1
Blood pressure
Angiotensins
Cardiomegaly
Renin-Angiotensin System
Nutrition
Malondialdehyde
Renin
Heart Ventricles

Keywords

  • Angiotensin-converting enzyme
  • Cardiovascular remodeling
  • Hypertension
  • Nitric oxide
  • Soy protein
  • Tumor necrosis factor

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Molecular Biology
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with l-NAME-induced hypertension. / Yang, Hsin Yi; Yang, Suh Ching; Chen, Shu Tzu; Chen, Jiun Rong.

In: Journal of Nutritional Biochemistry, Vol. 19, No. 12, 12.2008, p. 833-839.

Research output: Contribution to journalArticle

@article{29a2b7397df64e2da5ac251fd615598a,
title = "Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with l-NAME-induced hypertension",
abstract = "Pepsin-digested soy protein hydrolysate has been reported to be responsible for many of the physiological benefits associated with soy protein consumption. In the present study, we investigated the effects of soy protein hydrolysate with angiotensin-converting enzyme (ACE) inhibitory potential on the blood pressure and cardiovascular remodeling in rats with Nω-nitro-l-arginine methyl ester hydrochloride (l-NAME)-induced hypertension. Rats were fed a diet containing l-NAME (50 mg/kg body weight) with or without soy protein hydrolysate (1{\%}, 3{\%} or 5{\%}) for 6 weeks. We found that ingestion of soy protein hydrolysate retarded the development of hypertension during the 6-week experimental period without affecting the amount of food intake. Although there was no difference in plasma ACE activity or tissue nitric oxide levels, ACE activity in the heart of rats consuming soy protein hydrolysate was significantly lower than that of the control group. Moreover, cardiac malonaldehyde and tumor necrosis factor-α concentrations were also lower in the soy protein hydrolysate group. No difference in plasminogen activator inhibitor-1 level was found in plasma or cardiovascular tissue. In the histopathological analysis, we also found that soy protein hydrolysate ameliorated inflammation and left ventricle hypertrophy in the heart. These findings suggest that soy protein hydrolysate might not only improve the balance between circulating nitric oxide and renin-angiotensin system but also show beneficial effects on cardiovascular tissue through its ACE inhibitory activity.",
keywords = "Angiotensin-converting enzyme, Cardiovascular remodeling, Hypertension, Nitric oxide, Soy protein, Tumor necrosis factor",
author = "Yang, {Hsin Yi} and Yang, {Suh Ching} and Chen, {Shu Tzu} and Chen, {Jiun Rong}",
year = "2008",
month = "12",
doi = "10.1016/j.jnutbio.2007.11.004",
language = "English",
volume = "19",
pages = "833--839",
journal = "Journal of Nutritional Biochemistry",
issn = "0955-2863",
publisher = "Elsevier Inc.",
number = "12",

}

TY - JOUR

T1 - Soy protein hydrolysate ameliorates cardiovascular remodeling in rats with l-NAME-induced hypertension

AU - Yang, Hsin Yi

AU - Yang, Suh Ching

AU - Chen, Shu Tzu

AU - Chen, Jiun Rong

PY - 2008/12

Y1 - 2008/12

N2 - Pepsin-digested soy protein hydrolysate has been reported to be responsible for many of the physiological benefits associated with soy protein consumption. In the present study, we investigated the effects of soy protein hydrolysate with angiotensin-converting enzyme (ACE) inhibitory potential on the blood pressure and cardiovascular remodeling in rats with Nω-nitro-l-arginine methyl ester hydrochloride (l-NAME)-induced hypertension. Rats were fed a diet containing l-NAME (50 mg/kg body weight) with or without soy protein hydrolysate (1%, 3% or 5%) for 6 weeks. We found that ingestion of soy protein hydrolysate retarded the development of hypertension during the 6-week experimental period without affecting the amount of food intake. Although there was no difference in plasma ACE activity or tissue nitric oxide levels, ACE activity in the heart of rats consuming soy protein hydrolysate was significantly lower than that of the control group. Moreover, cardiac malonaldehyde and tumor necrosis factor-α concentrations were also lower in the soy protein hydrolysate group. No difference in plasminogen activator inhibitor-1 level was found in plasma or cardiovascular tissue. In the histopathological analysis, we also found that soy protein hydrolysate ameliorated inflammation and left ventricle hypertrophy in the heart. These findings suggest that soy protein hydrolysate might not only improve the balance between circulating nitric oxide and renin-angiotensin system but also show beneficial effects on cardiovascular tissue through its ACE inhibitory activity.

AB - Pepsin-digested soy protein hydrolysate has been reported to be responsible for many of the physiological benefits associated with soy protein consumption. In the present study, we investigated the effects of soy protein hydrolysate with angiotensin-converting enzyme (ACE) inhibitory potential on the blood pressure and cardiovascular remodeling in rats with Nω-nitro-l-arginine methyl ester hydrochloride (l-NAME)-induced hypertension. Rats were fed a diet containing l-NAME (50 mg/kg body weight) with or without soy protein hydrolysate (1%, 3% or 5%) for 6 weeks. We found that ingestion of soy protein hydrolysate retarded the development of hypertension during the 6-week experimental period without affecting the amount of food intake. Although there was no difference in plasma ACE activity or tissue nitric oxide levels, ACE activity in the heart of rats consuming soy protein hydrolysate was significantly lower than that of the control group. Moreover, cardiac malonaldehyde and tumor necrosis factor-α concentrations were also lower in the soy protein hydrolysate group. No difference in plasminogen activator inhibitor-1 level was found in plasma or cardiovascular tissue. In the histopathological analysis, we also found that soy protein hydrolysate ameliorated inflammation and left ventricle hypertrophy in the heart. These findings suggest that soy protein hydrolysate might not only improve the balance between circulating nitric oxide and renin-angiotensin system but also show beneficial effects on cardiovascular tissue through its ACE inhibitory activity.

KW - Angiotensin-converting enzyme

KW - Cardiovascular remodeling

KW - Hypertension

KW - Nitric oxide

KW - Soy protein

KW - Tumor necrosis factor

UR - http://www.scopus.com/inward/record.url?scp=55249084446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55249084446&partnerID=8YFLogxK

U2 - 10.1016/j.jnutbio.2007.11.004

DO - 10.1016/j.jnutbio.2007.11.004

M3 - Article

C2 - 18479899

AN - SCOPUS:55249084446

VL - 19

SP - 833

EP - 839

JO - Journal of Nutritional Biochemistry

JF - Journal of Nutritional Biochemistry

SN - 0955-2863

IS - 12

ER -